Frontiers in Microbiology,
Journal Year:
2022,
Volume and Issue:
12
Published: Jan. 3, 2022
Microbial
diseases
are
a
global
health
threat,
leading
to
tremendous
casualties
and
economic
losses.
The
strategy
treat
microbial
falls
into
two
broad
categories:
pathogen-directed
therapy
(PDT)
host-directed
(HDT).
As
the
typical
PDT,
antibiotics
or
antiviral
drugs
directly
attack
bacteria
viruses
through
discerning
specific
molecules.
However,
drug
abuse
could
result
in
antimicrobial
resistance
increase
infectious
disease
morbidity.
Recently,
exosome
therapy,
as
HDT,
has
attracted
extensive
attentions
for
its
potential
limiting
complications
targeted
delivery.
Mesenchymal
stem
cell-derived
exosomes
(MSC-Exos)
most
broadly
investigated.
In
this
review,
we
mainly
focus
on
development
recent
advances
of
application
MSC-Exos
diseases.
review
starts
with
difficulties
current
strategies
treatments,
followed
by
comprehensive
overview
aspect
isolation,
identification,
contents,
applications.
Then,
underlying
mechanisms
MSC-Exo
discussed
depth,
including
immunomodulation,
repression
excessive
inflammation,
promotion
tissue
regeneration.
addition,
highlight
latest
progress
clinical
translation
summarizing
related
trials,
routes
administration,
modifications.
This
will
provide
fundamental
insights
future
perspectives
from
bench
bedside.
Cells,
Journal Year:
2023,
Volume and Issue:
12(3), P. 493 - 493
Published: Feb. 2, 2023
The
outbreak
of
COVID-19
has
positively
impacted
the
NGS
market
recently.
Targeted
sequencing
(TS)
become
an
important
routine
technique
in
both
clinical
and
research
settings,
with
advantages
including
high
confidence
accuracy,
a
reasonable
turnaround
time,
relatively
low
cost,
fewer
data
burdens
level
bioinformatics
or
computational
demand.
Since
there
are
no
clear
consensus
guidelines
on
wide
range
next-generation
(NGS)
platforms
techniques,
is
vital
need
for
researchers
clinicians
to
develop
efficient
approaches,
especially
molecular
diagnosis
diseases
emergency
disease
global
pandemic
COVID-19.
In
this
review,
we
aim
summarize
different
methods
TS,
demonstrate
parameters
TS
assay
designs,
illustrate
panels,
discuss
their
limitations,
present
challenges
concerning
application
human
diseases.
Materials Today,
Journal Year:
2022,
Volume and Issue:
60, P. 201 - 226
Published: Sept. 29, 2022
Face
masks
have
been
used
as
the
most
effective
and
economically
viable
preventive
tool,
which
also
creates
a
sense
of
social
solidarity
in
collectively
combatting
airborne
health
hazards.
In
spite
enormous
research
literature,
massive
production,
competitive
market,
use
modern
age
face
masks-respirators
(FMR)
is
restricted
for
specific
purposes
or
during
public
emergencies.
It
attributed
to
lack
awareness,
prominent
myths,
architect
manufacturing
limitations,
concerns,
probable
solid
waste
management.
However,
efforts
dedicated
address
these
issues
through
using
materials
textiles
such
nanomaterials
mask
fabrication.
Conventional
FMRs
possess
bottlenecks
breathing
issues,
skin
problems,
single
use,
fungal
infections,
communication
barrier
differently
abled,
inefficiency
filter
minute
contaminants,
sourcing
secondary
contamination
issue
solid-waste
management
upon
usage.
Contrary,
FMR
engineered
with
functional
owing
high
surface
area,
unique
physicochemical
properties,
enriched
chemistries
challenges
due
smart
features
like
self-cleaning
ability,
biocompatibility,
transparency,
multiple
usages,
anti-contaminant,
good
breathability,
excellent
filtration
capacity,
pathogen
detecting
scavenging
capabilities.
This
review
highlights
state-of-the-art
different
dimensional
nanocomposites
combat
hazards,
especially
infectious
outbreaks
air
contamination.
Besides,
myths
facts
about
FMR,
associated
challenges,
potential
sustainable
solutions,
prospects
“point-of-action”
intelligent
operation
integration
internet-of-nano-things,
5G
wireless
communications,
artificial
intelligence
are
discussed.
Reviews in Medical Virology,
Journal Year:
2022,
Volume and Issue:
32(6)
Published: Feb. 9, 2022
Abstract
With
the
progression
of
investigations
on
pathogenesis
severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2),
neurological
complications
have
emerged
as
a
critical
aspect
ongoing
disease
2019
(Covid‐19)
pandemic.
Besides
well‐known
symptoms,
many
manifestations
such
anosmia/ageusia,
headaches,
dizziness,
seizures,
and
strokes
been
documented
in
hospitalised
patients.
The
neurotropism
background
coronaviruses
has
led
to
speculation
that
are
caused
by
direct
invasion
SARS‐CoV‐2
into
nervous
system.
This
is
proposed
occur
through
infection
peripheral
nerves
or
via
systemic
blood
circulation,
termed
neuronal
haematogenous
routes
invasion,
respectively.
On
other
hand,
aberrant
immune
responses
insufficiency
associated
with
Covid‐19
suggested
affect
system
indirectly.
Deleterious
roles
cytokine
storm
hypoxic
conditions
blood‐brain
barrier
disruption,
coagulation
abnormalities,
autoimmune
neuropathies
well
investigated
infections,
Covid‐19.
Here,
we
review
latest
discoveries
focussing
possible
molecular
mechanisms
indirect
impacts
try
elucidate
link
between
some
potential
therapeutic
strategies
pathways.
International Journal of Environmental Research and Public Health,
Journal Year:
2022,
Volume and Issue:
19(16), P. 10362 - 10362
Published: Aug. 19, 2022
The
physio-affective
phenome
of
Long
COVID-19
is
predicted
by
(a)
immune-inflammatory
biomarkers
the
acute
infectious
phase,
including
peak
body
temperature
(PBT)
and
oxygen
saturation
(SpO2),
(b)
subsequent
activation
immune
oxidative
stress
pathways
during
COVID.
purpose
this
study
was
to
delineate
effects
PBT
SpO2
infection,
as
well
increased
neurotoxicity
on
physical,
psychological,
social
environmental
domains
health-related
quality
life
(HR-QoL)
in
people
with
We
recruited
86
participants
COVID
39
normal
controls,
assessed
WHO-QoL-BREF
(World
Health
Organization
Quality
Life
Instrument-Abridged
Version,
Geneva,
Switzerland)
(comprising
depression,
anxiety
fibromyalgia-fatigue
rating
scales)
measured
(NT,
comprising
serum
interleukin
(IL)-1β,
IL-18
caspase-1,
advanced
oxidation
protein
products
myeloperoxidase,
calcium
insulin
resistance)
found
that
70.3%
variance
HR-QoL
explained
regression
phenome,
lowered
NT,
whilst
61.5%
calcium,
PBT,
SpO2,
female
sex
vaccination
AstraZeneca
Pfizer.
were
mediated
NT
yielding
severity
which
largely
affects
HR-QoL.
In
conclusion,
HR-Qol
neuro-immune
neuro-oxidative
Annals of Clinical Microbiology and Antimicrobials,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: May 19, 2023
Abstract
Objectives
This
meta-analysis
evaluated
the
Efficacy
and
Effectiveness
of
several
COVID-19
vaccines,
including
AstraZeneca,
Pfizer,
Moderna,
Bharat,
Johnson
&
Johnson,
to
better
estimate
their
immunogenicity,
benefits,
or
side
effects.
Methods
Studies
reporting
vaccines
from
November
2020
April
2022
were
included.
The
pooled
Effectiveness/Efficacy
with
a
95%
confidence
interval
(95%
CI)
Metaprop
order
was
calculated.
results
presented
in
forest
plots.
Predefined
subgroup
analyses
sensitivity
also
performed.
Results
A
total
twenty
articles
included
this
meta-analysis.
After
first
dose
vaccine,
effectiveness
all
our
study
71%
CI
0.65,
0.78).
after
second
91%
0.88,
0.94)).
efficacy
doses
81%
0.70,
0.91)
0.62,
0.79),
respectively.
Moderna
vaccine
highest
among
other
studied
((74%
CI,
0.83)
93%
0.89,
0.97),
respectively).
overall
against
Gamma
variant
(74%
0.73,
0.75)),
observed
Beta
(96%
0.96,
0.96)).
for
AstraZeneca
Pfizer
78%
0.95)
84%
0.77,
0.92),
Bharat
67%
0.54,
0.80),
0.85,
1.00),
0.61,
0.82),
vaccination
Alfa
0.84,
0.84)
77%
0.57,
respectively,
variants.
Conclusion
mRNA-based
showed
than
vaccines.
In
general,
administering
produced
more
reliable
response
higher
single
dose.
International Journal of Environmental Research and Public Health,
Journal Year:
2023,
Volume and Issue:
20(5), P. 3825 - 3825
Published: Feb. 21, 2023
The
spread
of
the
coronavirus
disease
2019
(COVID-19)
pandemic
caused
a
sudden
and
significant
disruption
in
healthcare
services,
especially
for
patients
suffering
from
chronic
diseases.
We
aimed
at
evaluating
impact
on
adherence
to
therapies
through
systematic
review
available
studies.
PubMed,
EMBASE,
Web
Science
were
searched
since
inception
June
2022.
Inclusion
criteria
were:
(1)
observational
studies
or
surveys;
(2)
with
diseases;
(3)
reporting
effects
COVID-19
pharmacological
treatment,
as
comparison
during
period
vs.
pre-pandemic
(primary
outcome)
rate
treatment
discontinuation/delay
specifically
due
factors
linked
(secondary
outcome).
Findings
12
24
showed
that
many
treatments
interrupted
affected
by
reduced
period,
fear
infection,
difficulty
reaching
physicians
facilities,
unavailability
medication
often
reported
reasons
discontinuation
modification
therapies.
For
other
where
patient
was
not
required
attend
clinic,
continuity
sometimes
ensured
use
telemedicine,
guaranteed
drug
stockpiling.
While
possible
worsening
management
need
be
monitored
over
time,
positive
strategies
should
acknowledged,
such
implementation
e-health
tools
expanded
role
community
pharmacists,
may
play
an
important
preserving
care
people
European Journal of Epidemiology,
Journal Year:
2023,
Volume and Issue:
38(4), P. 355 - 372
Published: Feb. 25, 2023
Abstract
Current
evidence
on
COVID-19
prognostic
models
is
inconsistent
and
clinical
applicability
remains
controversial.
We
performed
a
systematic
review
to
summarize
critically
appraise
the
available
studies
that
have
developed,
assessed
and/or
validated
of
predicting
health
outcomes.
searched
six
bibliographic
databases
identify
published
articles
investigated
univariable
multivariable
adverse
outcomes
in
adult
patients,
including
intensive
care
unit
(ICU)
admission,
intubation,
high-flow
nasal
therapy
(HFNT),
extracorporeal
membrane
oxygenation
(ECMO)
mortality.
identified
314
eligible
from
more
than
40
countries,
with
152
these
presenting
mortality,
66
progression
severe
or
critical
illness,
35
mortality
ICU
admission
combined,
17
only,
while
remaining
44
reported
prediction
for
mechanical
ventilation
(MV)
combination
multiple
The
sample
size
included
varied
11
7,704,171
participants,
mean
age
ranging
18
93
years.
There
were
353
investigated,
area
under
curve
(AUC)
0.44
0.99.
A
great
proportion
(61.5%,
193
out
314)
internal
external
validation
replication.
In
312
(99.4%)
studies,
be
at
high
risk
bias
due
uncertainties
challenges
surrounding
methodological
rigor,
sampling,
handling
missing
data,
failure
deal
overfitting
heterogeneous
definitions
severity
While
several
been
described
literature,
they
are
limited
generalizability
deficiencies
addressing
fundamental
statistical
concerns.
Future
large,
multi-centric
well-designed
prospective
needed
clarify
uncertainties.
BMJ Global Health,
Journal Year:
2023,
Volume and Issue:
8(12), P. e012581 - e012581
Published: Dec. 1, 2023
Introduction
Despite
a
growing
body
of
scholarly
research
on
the
risks
severe
COVID-19
associated
with
diabetes,
hypertension
and
obesity,
there
is
need
for
estimating
pooled
risk
estimates
adjustment
confounding
effects.
We
conducted
systematic
review
meta-analysis
to
estimate
adjusted
ratios
obesity
mortality.
Methods
searched
16
literature
databases
original
studies
published
between
1
December
2019
31
2020.
used
adapted
Newcastle-Ottawa
Scale
assess
bias.
Pooled
were
estimated
based
effect
sizes.
applied
random-effects
account
uncertainty
in
residual
heterogeneity.
contour-funnel
plots
Egger’s
test
possible
publication
Results
reviewed
34
830
records
identified
search,
which
145
included
meta-analysis.
1.43
(95%
CI
1.32
1.54),
1.19
1.09
1.30)
1.39
1.27
1.52)
(body
mass
index
≥30
kg/m
2
)
mortality,
respectively.
The
appeared
be
stronger
before
April
2020,
Western
Pacific
Region,
low-
middle-income
countries,
countries
low
Global
Health
Security
Index
scores,
when
compared
their
counterparts.
Conclusions
Diabetes,
an
increased
mortality
independent
other
known
factors,
particularly
low-resource
settings.
Addressing
these
chronic
diseases
could
important
global
pandemic
preparedness
prevention.
PROSPERO
registration
number
CRD42021204371.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8155 - 8155
Published: July 26, 2024
At
present,
COVID-19
remains
a
public
health
concern
due
to
the
ongoing
evolution
of
SARS-CoV-2
and
its
prevalence
in
particular
countries.
This
paper
provides
an
updated
overview
epidemiology
pathogenesis
COVID-19,
with
focus
on
emergence
variants
phenomenon
known
as
‘long
COVID’.
Meanwhile,
diagnostic
detection
advances
will
be
mentioned.
Though
many
inventions
have
been
made
combat
pandemic,
some
outstanding
ones
include
multiplex
RT-PCR,
which
can
used
for
accurate
diagnosis
infection.
ELISA-based
antigen
tests
also
appear
potential
tools
available
future.
discusses
current
treatments,
vaccination
strategies,
well
emerging
cell-based
therapies
The
underscores
necessity
us
continuously
update
scientific
understanding
treatments
it.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(23), P. 12638 - 12638
Published: Nov. 23, 2021
Several
coronaviruses
(CoVs)
have
been
associated
with
serious
health
hazards
in
recent
decades,
resulting
the
deaths
of
thousands
around
globe.
The
coronavirus
pandemic
has
emphasized
importance
discovering
novel
and
effective
antiviral
medicines
as
quickly
possible
to
prevent
more
loss
human
lives.
Positive-sense
RNA
viruses
group
spikes
protruding
from
their
surfaces
an
abnormally
large
genome
enclose
CoVs.
CoVs
already
related
a
range
respiratory
infectious
diseases
possibly
fatal
humans,
such
MERS,
SARS,
current
COVID-19
outbreak.
As
result,
prevention,
treatment,
medications
against
(HCoV)
is
urgently
needed.
In
years,
many
natural
substances
discovered
variety
biological
significance,
including
properties.
Throughout
this
work,
we
reviewed
wide
that
interrupt
life
cycles
for
MERS
well
potential
application
treatment
COVID-19.